Detalles de la búsqueda
1.
Stereoselective Synthesis and Biological Evaluation of C1-Epimeric and Desmethyl Monomeric Nuphar Analogues.
J Org Chem
; 82(5): 2648-2655, 2017 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28164703
2.
Enantioselective Formal Syntheses of 11 Nuphar Alkaloids and Discovery of Potent Apoptotic Monomeric Analogues.
Angew Chem Int Ed Engl
; 55(10): 3509-13, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26846359
3.
Total Syntheses and Biological Evaluation of Both Enantiomers of Several Hydroxylated Dimeric Nuphar Alkaloids.
Angew Chem Int Ed Engl
; 54(36): 10604-7, 2015 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26205039
4.
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): a potent, selective prostaglandin D2 receptor antagonist.
Bioorg Med Chem Lett
; 21(3): 1036-40, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21211969
5.
5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)-A potent FLAP inhibitor suitable for topical administration.
Bioorg Med Chem Lett
; 20(15): 4598-601, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20566292
6.
5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)--a potent FLAP inhibitor.
Bioorg Med Chem Lett
; 20(1): 213-7, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19914828
7.
Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
J Pharmacol Exp Ther
; 331(3): 1042-50, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19749079
8.
5-Lipoxygenase-activating protein (FLAP) inhibitors. Part 4: development of 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid (AM803), a potent, oral, once daily FLAP inhibitor.
J Med Chem
; 54(23): 8013-29, 2011 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22059882
9.
Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation.
Eur J Pharmacol
; 640(1-3): 211-8, 2010 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20519143
10.
5-lipoxygenase-activating protein inhibitors: development of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103).
J Med Chem
; 52(19): 5803-15, 2009 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-19739647
11.
Biocultural aspects of disease
Louisiana; Academic Press; 1981. 653 p.
Monografía
en Inglés
| LILACS, SES-SP, SESSP-ISPROD, SES-SP, SESSP-ISACERVO | ID: biblio-1072944
Resultados
1 -
11
de 11
1
Próxima >
>>